Get started
888

EXTRAWELL PHARMACEUTICAL HLDGS

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Seasonals

858 chart


Full chart

858 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪145.79 M‬ HKD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.068 HKD
Net income (FY)
‪−162.95 M‬ HKD
Revenue (FY)
‪59.10 M‬ HKD
Shares float
‪945.51 M‬
Beta (1Y)
0.89

Employees


Employees (FY)
159
Change (1Y)
−22 −12.15%
Revenue / Employee (1Y)
‪47.48 K‬ HKD
Net income / Employee (1Y)
‪−130.92 K‬ HKD

About EXTRAWELL PHARMACEUTICAL HLDGS


Sector
Health Technology
CEO
Yi Xie
Headquarters
Hong Kong
Website
extrawell.com.hk
Founded
1998
FIGI
BBG000BSKPT6
Extrawell Pharmaceutical Holdings Ltd. is an investment company, which engages in the marketing and distribution of pharmaceutical products. It operates through the following segments: Manufacturing, Trading, and Gene Development. The Manufacturing segment includes the development, manufacture, and sale of pharmaceutical products. The Trading segment covers the marketing and distribution of imported pharmaceutical products. The Gene Development segment focuses on the commercial exploitation and development of genome-related technology. The company was founded on December 8, 1998 and is headquartered in Hong Kong.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

858 news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 858 is 0.056 HKD — it has decreased by −9.84% in the past 24 hours. Watch EXTRAWELL PHARMACEUTICAL HLDGS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange EXTRAWELL PHARMACEUTICAL HLDGS stocks are traded under the ticker 858.
858 stock has risen by 12.24% compared to the previous week, the month change is a 14.58% rise, over the last year EXTRAWELL PHARMACEUTICAL HLDGS has showed a 47.37% increase.
858 reached its all-time high on Jun 12, 2007 with the price of 3.920 HKD, and its all-time low was 0.026 HKD and was reached on Apr 22, 2024. View more price dynamics on 858 chart.
See other stocks reaching their highest and lowest prices.
858 stock is 10.91% volatile and has beta coefficient of 0.89. Track EXTRAWELL PHARMACEUTICAL HLDGS stock price on the chart and check out the list of the most volatile stocks — is EXTRAWELL PHARMACEUTICAL HLDGS there?
Today EXTRAWELL PHARMACEUTICAL HLDGS has the market capitalization of ‪145.79 M‬, it has increased by 24.49% over the last week.
Yes, you can track EXTRAWELL PHARMACEUTICAL HLDGS financials in yearly and quarterly reports right on TradingView.
EXTRAWELL PHARMACEUTICAL HLDGS is going to release the next earnings report on Nov 27, 2024. Keep track of upcoming events with our Earnings Calendar.
858 net income for the last half-year is ‪74.78 M‬ HKD, while the previous report showed ‪−237.72 M‬ HKD of net income which accounts for 131.45% change. Track more EXTRAWELL PHARMACEUTICAL HLDGS financial stats to get the full picture.
No, 858 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 159.00 employees. See our rating of the largest employees — is EXTRAWELL PHARMACEUTICAL HLDGS on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EXTRAWELL PHARMACEUTICAL HLDGS EBITDA is ‪−2.59 M‬ HKD, and current EBITDA margin is −4.50%. See more stats in EXTRAWELL PHARMACEUTICAL HLDGS financial statements.
Like other stocks, 858 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EXTRAWELL PHARMACEUTICAL HLDGS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EXTRAWELL PHARMACEUTICAL HLDGS technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EXTRAWELL PHARMACEUTICAL HLDGS stock shows the buy signal. See more of EXTRAWELL PHARMACEUTICAL HLDGS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.